Login
From:
BioSpace
(Uncensored)
subscribe
BMS Adds $2B to Cost Cutting Plans, Eyes Deals After Cobenfy Success - BioSpace
https://www.biospace.com/business/bms-adds-2b-to-cost-cutting-plans-eyes-deals-after-cobenfy-success
links
backlinks
Tagged with:
earnings
layoffs
pipeline
aggregate
Bristol Myers Squibb will make even deeper cuts to its organization to enhance efficiencies as it faces the 2028 loss of exclusivity for its blockbuster drugs Eliquis and Opdivo.
Roast topics
Find topics
Find it!
